Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - DEFERRED INCOME TAX
Deferred Income Tax ABUS - Arbutus Biopharma Corporation
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
7.18%
10 YEAR CAGR